MAP1LC3A and myotonic dystrophy type 1: In addition, after treatment with GFP-mRFP-LC3, the GFP/mRFP per cell in DM1-03 SSCs was significantly lower than that in DM1-04 SSCs, while that in DM1-13-3 SSCs was higher than that in DM1-03 SSCs, but lower than that in DM1-04 SSCs (Fig. 4k, l).